Clean Biologics (ex Clean Cells) Revenue and Competitors
Estimated Revenue & Valuation
- Clean Biologics (ex Clean Cells)'s estimated annual revenue is currently $22.5M per year.
- Clean Biologics (ex Clean Cells)'s estimated revenue per employee is $155,000
Employee Data
- Clean Biologics (ex Clean Cells) has 145 Employees.
- Clean Biologics (ex Clean Cells) grew their employee count by 4% last year.
Clean Biologics (ex Clean Cells)'s People
| Name | Title | Email/Phone |
|---|
Clean Biologics (ex Clean Cells) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Clean Biologics (ex Clean Cells)?
CLEAN CELLS is a 18 y/o CRO specialized in Biosafety Testing, viral clearance, cell and virus bank manufacturing and development of customized assays. We offer an alternative to big service-contract companies: Our channels of communication are simple and direct. CLEAN CELLS is a certified Pharmaceutical Company committed to deliver high-level quality services such as: 1. GLP biosafety testing, viral clearance study and mycoplasma elimination to ensure the quality of your product and your process. 2. cGMP biomanufacturing, characterization and storage of cell banks (MCB, WCB) and virus banks (MVSS, WVSS) in BSL-2, BSL-3 labs. 3. Development of any customized GLP assays (ADCC, CDC, …) in order to measure the efficacy of biological products (vaccines and immunotherapies), applicable for early development stage as well as lot release. Clean Cells proposes customized services with direct communication with our Scientists to offer an alternative to big service-contract companies. Our customers are global biopharmaceutical companies, contract manufacturing organizations, cell culture product manufacturers, early clinical-stage companies, contract research organizations and research academic laboratories.
keywords:N/A
N/A
Total Funding
145
Number of Employees
$22.5M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in boufféré
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $73.1M | 246 | 7% | N/A |
#2 | $173.7M | 864 | 20% | N/A |